AsadDurraniMD

Retinal Disease

Physician

Dr. Durrani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Surgical Retina and Vitreous, 2022 - 2024
University of Michigan Health SystemResidency, Ophthalmology, 2019 - 2022
University of Pittsburgh School of MedicineClass of 2018

PubMed

71 citations
Appropriateness and Readability of ChatGPT-4-Generated Responses for Surgical Treatment of Retinal Diseases.
Bita Momenaei, Taku Wakabayashi, Abtin Shahlaee, Asad F Durrani, Saagar A Pandit
Ophthalmology. Retina. 2023-10-01
2 citations
Rates of Ocular Adverse Events after Intravitreal Faricimab Injections.
Bita Momenaei, Kristine Wang, Adina S Kazan, Glenn J Oh, Roselind L Ni
Ophthalmology. Retina. 2024-03-01
9 citations
Risk Factors for Endophthalmitis Following Open Globe Injuries: A 17-Year Analysis.
Asad Farooq Durrani, Peter Y. Zhao, Yunshu Zhou, Michael J. Huvard, Lyna Azzouz
Clinical Ophthalmology. 2021-05-18

2023 Wills Eye Conference Presentations: Top Retina TakeawaysMarch 24th, 2023
Conducting Impactful Research as a Retina FellowMarch 2nd, 2023
Emerging Oral Pharmaceuticals for Dry Age-Related Macular Degeneration: Mechanism of Action, Current Clinical Status, and Future DirectionsJuly 1st, 2024